Latest News and Press Releases

Silver Spring, MD, July 29, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration today licensed Ezplaz Freeze Dried Plasma (FDP), making it the first freeze-dried plasma product licensed...

ADMA Biologics Investor Deadline in Securities Fraud Class Action is August 10 – Contact BFA Law if You Lost Money

Ahead of the official opening of AGC Biologics’ Yokohama site, a customer has already secured half of the facility’s manufacturing capacity.

ADMA Biologics Sued for Fraud Over Misrepresentations about Channel Stuffing – Investors Notified to Contact BFA Law

Alira Health today released the 2026 Biologics Contract Manufacturing Report, its annual analysis of the global CDMO market.

ADMA Biologics Investors Seeking to Recover Losses in Securities Fraud Class Action are Notified to Contact BFA Law before August 10 Deadline

ADMA Biologics Accused of Misrepresentations about its Revenue Sources in Securities Fraud Class Action – Investors Notified to Contact BFA Law

Important ADMA Biologics Deadline in Securities Fraud Class Action is Approaching – Investors Notified to Contact BFA Law by August 10

ADMA Biologics Investors may have been Misled after Channel Stuffing Claims Lead to 29% Stock Drop – Contact BFA Law if You Lost Money

ADMA Biologics Misrepresentations about Channel Stuffing Under Review in Securities Fraud Class Action – Contact BFA Law if You Lost Money